Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Altimmune Inc (NQ: ALT )

4.285 -0.135 (-3.05%)
Streaming Delayed Price Updated: 12:16 PM EDT, Mar 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 890,913
Open 4.450
Bid (Size) 4.280 (7)
Ask (Size) 4.290 (8)
Prev. Close 4.420
Today's Range 4.230 - 4.570
52wk Range 3.830 - 23.49
Shares Outstanding 49,278,861
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Should You Buy Viking Therapeutics Stock After It Skyrocketed Over 60%?
Viking could have a strong rival to Novo Nordisk's Wegovy and Ozempic and Lilly's Mounjaro in the making. 
Via The Motley Fool
Is Viking Therapeutics a Smart Buy on the Dip?
The stock recently fell around 25% for reasons that had nothing to do with its lead program. 
Via The Motley Fool

Performance

YTD
-72.58%
-72.58%
1 Month
-63.78%
-63.78%
3 Month
-71.09%
-71.09%
6 Month
-64.96%
-64.96%
1 Year
-31.00%
-31.00%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For March 22, 2023
Via Benzinga
Wall Street Absolutely Loved This Biotech Stock. But It Just Crashed More Than 50%.
Via The Motley Fool
Analyst Ratings for Altimmune
Via Benzinga
Looking Into Altimmune's Return On Capital Employed
Via Benzinga
Earnings Outlook For Altimmune
Via Benzinga
4 Analysts Have This to Say About Altimmune
Via Benzinga
Nasdaq Up Over 100 Points; Crude Oil Rises 2%
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Citi Trends Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Altimmune Touts Encouraging Data From Fatty Liver Disease Study
Via Benzinga
Gold Drops Over 1%; Existing Home Sales Surge In February
Via Benzinga
META Stock Price Prediction: Can Meta Platforms Really Hit $250?
Via InvestorPlace
Why Is Altimmune (ALT) Stock Down 67% Today?
Via InvestorPlace
US Stocks Open Higher; Nasdaq Jumps Over 100 Points
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Altimmune Stock Is Diving: What's Going On?
Via Benzinga
Why Altimmune, Foghorn Therapeutics, and Precigen Shares Crashed This Week
Via The Motley Fool
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
7 Small-Cap Stocks with Big Growth Potential in 2023
Via InvestorPlace
Lucid Group, Verona Pharma And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Via Benzinga
Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.